外体miRNAs:心血管疾病诊断和治疗的新前沿
1Department of Cardiology, Shanghai Tenth People's Hospital, Tongji University School of Medicine, 301Yanchang Road, Shanghai, 200072, China.
Journal of cardiovascular translational research
|June 19, 2025
概括
外体和它们的微RNA (miRNA) 是心血管疾病 (CVD) 的关键参与者. 本综述探讨了它们在心血管疾病中的作用,强调了它们在诊断和治疗方面的潜力.
科学领域:
- 生物化学 生物化学
- 分子生物学分子生物学
- 心脏病学 心脏病学
背景情况:
- 外体是细胞分泌的脂质双层囊泡,在微RNA (miRNA) 中丰富.
- 外体miRNAs在心血管疾病 (CVD) 的发病和进展中发挥着重要作用.
研究的目的:
- 审查外体和外体miRNA在心血管疾病中的生物特征,表达和作用机制.
- 探索外体miRNAs作为CVD诊断,治疗和预后生物标志物的潜力.
主要方法:
- 对心血管疾病中的外体和外体miRNAs现有研究的文献综述.
- 对与心血管疾病相关的外体miRNAs的生物学特性和功能的分析.
主要成果:
- 外体miRNAs与各种心血管疾病的发展和进展有关.
- 它们的独特特性表明它们可能成为治疗点和心血管疾病的诊断/预后生物标志物.
结论:
- 外体和外体miRNAs代表了心血管医学的一个有前途的前沿.
- 对外体miRNA的进一步研究可能会导致管理心血管疾病的新策略.
相关概念视频
Overview of Exosomes
2.9K
Exosomes are stable, lipid bilayer-enclosed vesicles capable of crossing biological barriers. They can carry a wide range of molecules required for intercellular communication. Once exosomes are released from the cell where they originated, they enter a recipient cell through various pathways such as fusion, receptor-mediated endocytosis, macropinocytosis, and phagocytosis.
Stahl et al. discovered exosomes in 1983, but the exosomes were initially considered waste products released from the...
Stahl et al. discovered exosomes in 1983, but the exosomes were initially considered waste products released from the...
2.9K
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
353
Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
353
MicroRNAs
3.1K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.1K
Coronary Artery Disease I: Introduction
69
Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
69
Cardiomyopathy I: Introduction and Classification
72
Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
72


